Advanced glycation end-products as a potential target for treatment of cardiovascular disease.
Silacci
Paolo
P
D000818:Animals; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000378:metabolism*; D017127:Glycation End Products, Advanced / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D051381:Rats; D013830:Thiadiazoles / Q000627:therapeutic use; D053778:Thiazolidines
D017127:Glycation End Products, Advanced; C105739:OPB 9195; D013830:Thiadiazoles; D053778:Thiazolidines